Solid state characterisation of silver sulfadiazine loaded on montmorillonite/chitosan nanocomposite for wound healing

Colloids and Surfaces B: Biointerfaces

Volumn 113, Issue , 2014, Pages 152-157

  Aguzzi, Carola ^a   Sandri, Giuseppina ^b   Bonferoni, Cristina ^b   Cerezo, Pilar ^a   Rossi, Silvia ^b   Ferrari, Franca ^b   Caramella, Carla ^b   Viseras, César ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chitosan; Montmorillonite; Nanocomposites; Silver sulfadiazine; Solid state characterisation

Indexed keywords

CHITOSAN; CLAY MINERALS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INFRARED SPECTROSCOPY; SILVER; X RAY DIFFRACTION;

FOURIER TRANSFORMED INFRARED SPECTROSCOPY; MINERAL INTERLAYERS; NANO-COMPOSITE STRUCTURE; PURE COMPONENTS; SILVER SULFADIAZINES; SOLUTION TECHNIQUES; STRUCTURE AND MORPHOLOGY; WOUND HEALING;

NANOCOMPOSITES;

CHITOSAN; MONTMORILLONITE; NANOCOMPOSITE; SULFADIAZINE SILVER;

ADSORPTION; ANALYTIC METHOD; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CLAY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELEMENTAL ANALYSIS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INFRARED SPECTROSCOPY; INTERCALATION COMPLEX; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; SOLID STATE; THERMAL ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING; X RAY ANALYSIS; X RAY DIFFRACTION;

CHITOSAN; MONTMORILLONITE; NANOCOMPOSITES; SILVER SULFADIAZINE; SOLID STATE CHARACTERISATION;

BENTONITE; CHITOSAN; NANOCOMPOSITES; SILVER SULFADIAZINE; WOUND HEALING;

EID: 84884541119     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.08.043     Document Type: Article

References (31)

1. Church D., et al. Burn wound infections. Clin. Microbiol. Rev. 2006, 19:403-434.
2. Atiyeh B.S., et al. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007, 33:139-148.
3. Stephen-Haynes J., Toner L. Assessment and management of wound infection: the role of silver. Br. J. Commun. Nurs. 2007, 12(3):S6. S8, S10-12.
4. Elliott C. The effects of silver dressings on chronic and burns wound healing. Br. J. Nurs. 2010, 19(15):S32-S36.
5. Politano A.D., et al. Use of silver in the prevention and treatment of infections: silver review. Surg. Infect. (Larchmt) 2013, 14(1):8-20.
6. Fuller F.W. The side effects of silver sulfadiazine. J. Burn Care Res. 2009, 30(3):464-470.
7. Rai M., et al. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 2009, 27(1):76-83.
8. Liu H.L., et al. Antibacterial properties of silver nanoparticles in three different sizes and their nanocomposites with a new waterborne polyurethane. Int. J. Nanomed. 2010, 5:1017-1028.
9. Dallas P., et al. Silver polymeric nanocomposites as advanced antimicrobial agents: classification, synthetic paths, applications, and perspectives. Adv. Colloid Interface Sci. 2011, 166:119-135.
10. Zapata P.A., et al. Nanocomposites based on polyethylene and nanosilver particles produced by metallocenic "in situ" polymerization: synthesis, characterisation, and antimicrobial behavior. Eur. Polym. J. 2011, 47:1541-1549.
11. Abedini F., et al. Comparison of silver nylon wound dressing and silver sulfadiazine in partial burn wound therapy. Int. Wound J. 2012, 1-7.
12. Chu C.Y., et al. Nanohybrids of silver particles immobilized on silicate platelet for infected wound healing. PLoS One 2012, 7:1-7.
13. Viseras C., et al. Biopolymer-clay nanocomposites for controlled drug delivery. Mater. Sci. Technol. 2008, 24:1020-1026.
14. Viseras C., et al. Current challenges in clay minerals for drug delivery. Appl. Clay Sci. 2010, 48:291-295.
15. Darder M., et al. Biopolymer-clay nanocomposites based on chitosan intercalated in montmorillonite. Chem. Mater. 2003, 15(20):3774-3780.
16. Wang S., et al. Biopolymer chitosan/montmorillonite nanocomposites: preparation and characterisation. Polym. Degrad. Stabil. 2005, 90:123-319.
17. Günister E., et al. Synthesis and characterisation of chitosan-MMT biocomposite systems. Carbohydr. Polym. 2007, 67:358-365.
18. Muzzarelli R.A.A. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr. Polym. 2009, 76:167-182.
19. Han Y.S., et al. Preparation and characterisation of chitosan-clay nanocomposites with antimicrobial activity. J. Phys. Chem. Solids 2010, 71:464-467.
20. Hsu S.H., et al. Biocompatibility and antimicrobial evaluation of montmorillonite/chitosan nanocomposites. Appl. Clay Sci. 2012, 56:53-62.
21. Liu M., et al. Chitosan/halloysite nanotubes bionanocomposites: structure, mechanical properties and biocompatibility. Int. J. Biol. Macromol. 2012, 51:566-575.
22. Salcedo I., et al. In vitro biocompatibility and mucoadhesion of montmorillonite chitosan nanocomposite: a new drug delivery. Appl. Clay Sci. 2012, 55:131-137.
23. Aguzzi C., et al. Influence of dispersion conditions of two pharmaceutical grade clays on their interaction with some tetracyclines. Appl. Clay Sci. 2005, 30(2):79-86.
24. Sandri G., et al. Nanocomposites based on montorillonite, chitosan and silver sulfadiazine intended for wound healing. Proc. 39th Annual Meeting & Exposition of the Controlled Release Society 2012.
25. Martín-Ramos J.D. X-Powder, a software package for powder X-ray diffraction analysis. Legal Deposit G.R.1001/04 2004, http://www.xpowder.com.
26. Bult A., Plug C.M. Analytical Profiles of Drug Substances 1984, 13:553-571. Academic Press, London.
27. + montmorillonites. Spectrochim. Acta, Part A 1999, 55:2467-2476.
28. 2) via ATR-FTIR spectroscopy and quantum chemical calculations. Langmuir 2011, 27(5):1778-1787.
29. Fajnor V.S., Jesendk K. Differential thermal analysis of montmorillonite. J. Therm. Anal. 1996, 46:489-493.
30. Maestrelli F., et al. Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int. J. Pharm. 2004, 271(1-2):257-267.
31. USP 36-NF 31.United States Pharmacopoeia-National Formulary The United States Pharmacopoeial Convention 2012, Rockville, MD.